| P2093 | author name string | Andrzej Pomianowski | |
| | Izabella Babińska | |
| | Andrzej Rychlik | |
| | Marta Szweda | |
| P2860 | cites work | Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation | Q22010150 |
| | COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression | Q24536398 |
| | The cyclooxygenases | Q24801433 |
| | Cancer-related inflammation | Q27860907 |
| | Cyclooxygenases in cancer: progress and perspective | Q28213081 |
| | The spinal phospholipase-cyclooxygenase-prostanoid cascade in nociceptive processing | Q28216388 |
| | Hypoxia-inducible factor (HIF-1)alpha: its protein stability and biological functions | Q28251400 |
| | Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues | Q28262266 |
| | Apoptosis: a review of programmed cell death | Q28305845 |
| | Non-small cell lung cancer cyclooxygenase-2-dependent invasion is mediated by CD44 | Q28363575 |
| | The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2 | Q28375904 |
| | Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2) | Q28586461 |
| | Angiogenesis in cancer, vascular, rheumatoid and other disease | Q29547165 |
| | Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas | Q29620630 |
| | The immune contexture in human tumours: impact on clinical outcome | Q29620667 |
| | [Cyclooxygenase and prostanoids--biological implications]. | Q30353477 |
| | Cyclooxygenase-2 expression in human colorectal cancer is unrelated to overall patient survival | Q33218334 |
| | The role of alphav integrins during angiogenesis: insights into potential mechanisms of action and clinical development. | Q33606824 |
| | Tumor formation in a mouse model of colitis-associated colon cancer does not require COX-1 or COX-2 expression | Q33759698 |
| | The role of cyclooxygenases in inflammation, cancer, and development | Q33814331 |
| | Regulation of angiogenesis via vascular endothelial growth factor receptors. | Q33833625 |
| | Cyclooxygenase-2--10 years later | Q34502904 |
| | Cyclooxygenase (COX) 1 and 2 in normal, inflamed, and ulcerated human gastric mucosa | Q34511855 |
| | Prostaglandin E2 regulates tumor angiogenesis in prostate cancer | Q34842324 |
| | Apoptosis in cancer: from pathogenesis to treatment | Q35397889 |
| | Alternative vascularization mechanisms in cancer: Pathology and therapeutic implications. | Q35570450 |
| | Augmented expression of cyclooxygenase-2 in human atherosclerotic lesions | Q35788328 |
| | Multifaceted roles of cyclooxygenase-2 in lung cancer | Q35856961 |
| | Apoptosis in the development and treatment of cancer | Q35890843 |
| | Cyclooxygenase-2 expression in equine tumors | Q79789621 |
| | [Angiogenesis and neoangiogenesis--the role in lung cancer and other tumors] | Q80142771 |
| | Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells | Q80274418 |
| | Species-specific expression of microsomal prostaglandin E synthase-1 and cyclooxygenases in male monkey reproductive organs | Q80430943 |
| | Activating apoptosis | Q83983178 |
| | COX-2 is overexpressed in primary prostate cancer with metastatic potential and may predict survival. A comparison study between COX-2, TGF-beta, IL-10 and Ki67 | Q84088624 |
| | [Tumor blood vessels] | Q84513343 |
| | [Epithelial-mesenchymal transition in cancer progression] | Q84710007 |
| | Positive Interplay Between CD3+ T-lymphocytes and Concurrent COX-2/EGFR Expression in Canine Malignant Mammary Tumors. | Q50978298 |
| | Plasma concentration and activity of matrix metalloproteinase 2 and 9 in patients with breast disease, breast cancer and at risk of developing breast cancer. | Q51819517 |
| | Retrospective evaluation of COX-2 expression, histological and clinical factors as prognostic indicators in dogs with renal cell carcinomas undergoing nephrectomy. | Q51830405 |
| | Localization of cyclooxygenase-1 and -2 in adult and fetal human kidney: implication for renal function. | Q52195455 |
| | High COX-2 expression in canine mast cell tumours is associated with proliferation, angiogenesis and decreased overall survival. | Q52773381 |
| | Adjuvant therapy for highly malignant canine mammary tumours: Cox-2 inhibitor versus chemotherapy: a case-control prospective study. | Q53073419 |
| | Investigating associations of cyclooxygenase-2 expression with angiogenesis, proliferation, macrophage and T-lymphocyte infiltration in canine melanocytic tumours. | Q53117077 |
| | Cyclooxygenase-2 mediated regulation of E-cadherin occurs in conventional but not early-onset gastric cancer cell lines. | Q53304373 |
| | Expression of cyclooxygenase-2 in Hodgkin's lymphoma: its role in cell proliferation and angiogenesis. | Q53340666 |
| | [Mechanisms of metastasis and molecular markers of malignant tumor progression. I. Colorectal cancer]. | Q53341454 |
| | COX-2 is expressed in human pulmonary, colonic, and mammary tumors. | Q53402915 |
| | Association of COX-2 expression with corresponding active and chronic inflammatory reactions in Barrett's metaplasia and progression to cancer. | Q53744935 |
| | Total cyclooxygenase-2 mRNA levels correlate with vascular endothelial growth factor mRNA levels, tumor angiogenesis and prognosis in non-small cell lung cancer patients. | Q54681218 |
| | Characteristics and Clinical Impacts of the Immune Environments in Colorectal and Renal Cell Carcinoma Lung Metastases: Influence of Tumor Origin | Q56965716 |
| | Combination of radiation therapy and firocoxib for the treatment of canine nasal carcinoma | Q56970317 |
| | The Relative Abundance of Type 1 to Type 2 Cyclo-oxygenase mRNA in Human Amnion at Term | Q58450615 |
| | COX-2, mPGES-1 and EP2 receptor immunohistochemical expression in canine and feline malignant mammary tumours | Q59713373 |
| | The 3'-untranslated region of murine cyclooxygenase-2 contains multiple regulatory elements that alter message stability and translational efficiency | Q73733182 |
| | Hepatocyte growth factor inhibits anoikis by induction of activator protein 1-dependent cyclooxygenase-2. Implication in head and neck squamous cell carcinoma progression | Q78410915 |
| | Antiangiogenic therapy: impact on invasion, disease progression, and metastasis. | Q35966757 |
| | Adverse cardiovascular effects of the coxibs | Q36084983 |
| | Renal effects of non-steroidal anti-inflammatory drugs and selective cyclooxygenase-2 inhibitors | Q36126752 |
| | Integrating tumor microenvironment with cancer molecular classifications | Q36278354 |
| | Signalling networks regulating cyclooxygenase-2. | Q36483419 |
| | Bcl-2-regulated apoptosis: mechanism and therapeutic potential | Q36880621 |
| | Cyclooxygenase-2 expression is an independent predictor of poor prognosis in colon cancer | Q37185554 |
| | Progression of pancreatic adenocarcinoma is significantly impeded with a combination of vaccine and COX-2 inhibition. | Q37338140 |
| | The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment | Q37366259 |
| | Two pathways for cyclooxygenase-2 protein degradation in vivo | Q37431312 |
| | The angiogenic switch in carcinogenesis | Q37501499 |
| | Inflammation-mediated promotion of invasion and metastasis | Q37736304 |
| | Targeting the tumour vasculature: insights from physiological angiogenesis | Q37767356 |
| | Cyclooxygenase-2 Expression in Animal Cancers | Q37793667 |
| | Cyclooxygenase-2 in oncogenesis | Q37824155 |
| | Prostanoids in tumor angiogenesis: therapeutic intervention beyond COX-2. | Q37994484 |
| | COX-2 is associated with proliferation and apoptosis markers and serves as an independent prognostic factor in gastric cancer | Q38417416 |
| | Hyaluronan constitutively regulates activation of COX-2-mediated cell survival activity in intestinal epithelial and colon carcinoma cells | Q38531398 |
| | Citrate and celecoxib induce apoptosis and decrease necrosis in synergistic manner in canine mammary tumor cells | Q38827286 |
| | Celecoxib exerts antitumor effects in canine mammary tumor cells via COX‑2‑independent mechanisms | Q39062494 |
| | Cyclooxygenase-2 inhibitor, nimesulide, improves radiation treatment against non-small cell lung cancer both in vitro and in vivo | Q40232776 |
| | Cyclooxygenase-2 inhibitor enhances the efficacy of a breast cancer vaccine: role of IDO. | Q40247859 |
| | Cyclooxygenase-2-dependent regulation of E-cadherin: prostaglandin E(2) induces transcriptional repressors ZEB1 and snail in non-small cell lung cancer. | Q40278675 |
| | Cyclooxygenase 2-dependent expression of survivin is critical for apoptosis resistance in non-small cell lung cancer | Q40514782 |
| | Akt/PKB promotes cancer cell invasion via increased motility and metalloproteinase production | Q40782729 |
| | Tumor-Expressed IDO Recruits and Activates MDSCs in a Treg-Dependent Manner | Q41031486 |
| | Meloxicam decreases the migration and invasion of CF41.Mg canine mammary carcinoma cells. | Q41145128 |
| | Apoptosis: pathophysiology of programmed cell death | Q41176259 |
| | Specific inhibition of cyclooxygenase 2 restores antitumor reactivity by altering the balance of IL-10 and IL-12 synthesis | Q41709477 |
| | Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids | Q42506522 |
| | Akt kinase: a key regulator of metabolism and progression of tumors | Q42850898 |
| | Caveolin-1 facilitates cyclooxygenase-2 protein degradation. | Q43230022 |
| | Cyclooxygenase-2-issued prostaglandin e(2) enhances the production of endogenous IL-10, which down-regulates dendritic cell functions | Q43891702 |
| | Bone marrow cyclooxygenase-2 levels are elevated in chronic-phase chronic myeloid leukaemia and are associated with reduced survival | Q44163463 |
| | Non-small cell lung cancer cyclooxygenase-2-dependent regulation of cytokine balance in lymphocytes and macrophages: up-regulation of interleukin 10 and down-regulation of interleukin 12 production. | Q44214443 |
| | Potentiation of tumor response to radiation or chemoradiation by selective cyclooxygenase-2 enzyme inhibitors | Q44748389 |
| | Eicosanoid modulation in advanced lung cancer: cyclooxygenase-2 expression is a positive predictive factor for celecoxib + chemotherapy--Cancer and Leukemia Group B Trial 30203. | Q46748115 |
| | Overexpression of cyclooxygenase-2 in multiple myeloma: association with reduced survival | Q46773010 |
| | Cyclooxygenase and inflammation in Alzheimer's disease: experimental approaches and clinical interventions | Q48373314 |
| P275 | copyright license | Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported | Q19125045 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 2 | |
| P304 | page(s) | 215-224 | |
| P577 | publication date | 2019-06-12 | |
| P1476 | title | Significance of Cyclooxygenase-2 in Oncogenesis | |
| P478 | volume | 63 | |